AN INTRODUCTION TO THE NAGOYA PROTOCOLNagoya Protocol • May 22nd, 2019
The Nagoya Protocol on Access and Benefit Sharing (ABS) is a 2010 supplementary agreement to the 1992 Convention on Biological Diversity (CBD). The Protocol aims to prevent unregulated commercial exploitation of the word’s naturally occurring genetic resources, and contribute to the conservation and sustainable use of biodiversity, to ensure resulting benefits are distributed equitably and fairly and that there is no restriction on their future use.
Nagoya Protocol is in force since 12 October 2014: South Asia, are we ready for new ABS regime?Nagoya Protocol • February 23rd, 2016
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits (ABS) Arising from their Utilization to the Convention on Biological Diversity (CBD) is an international agreement which aims at sharing the benefits arising from the utilization of genetic resources in a fair and equitable way. It entered into force on 12 October 2014, 90 days after the date of deposit of the fiftieth instrument of ratification. Since then, after nearly one and half years, 71 countries have ratified the protocol became parties to it. The Convention on Biological Diversity and Cartagena Protocol on Biosafety have 196 parties and 170 parties respectively. So far, three out of 8 South Asian countries (Bhutan, India and Pakistan) have ratified the Nagoya Protocol.
The Nagoya Protocol at Its 5th Anniversary: Legal Lessons Learned in the Pharmaceutical, Food and Cosmetics SectorsNagoya Protocol • September 17th, 2019
The Nagoya Protocol on Access and Benefit Sharing is the main global mechanism to regulate the access and utilization of biological resources. The agreement entered into force nearly five years ago, on October 12, 2014, as a supplement to the 1992 Convention on Biological Diversity. Today, 118 countries are a contracting party to the Protocol. The volume of national implementing rules has continued to proliferate, and with that, the impact on pharmaceutical, food, cosmetics, and other life sciences companies has become increasingly apparent.
Nagoya is the city in Japan where the all the officials got together in 2010 to adopt the Protocol and to make it a legal agreement in all their countriesNagoya Protocol • September 20th, 2019
The Nagoya Protocol was developed to protect the rights of the owners of their genetic resources and of traditional knowledge.
